Physician profile
David M Dick
NPI 1477548618
$6,596.10
in general payments reported to CMS, 2019-2025
23 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $784 · 2021: $1,221 · 2022: $1,316 · 2023: $1,337 · 2024: $704 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,386.02 | 2019-2025 | |
| Amgen INC. | $1,297.06 | 2019-2025 | Repatha |
| Medtronic, INC. | $1,023.25 | 2021-2024 | Onyx Frontier, Viance, Turbohawk |
| Janssen Pharmaceuticals, INC | $636.03 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.68 | 2019-2023 | Lifevest |
| Pfizer INC. | $428.66 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $332.73 | 2019-2024 | Farxiga |
| Medtronic Vascular, INC. | $263.84 | 2019-2020 | |
| Cvrx, INC. | $107.08 | 2022 | |
| Merck Sharp & Dohme LLC | $98.46 | 2022-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $77.21 | 2019-2024 | |
| Amarin Pharma, INC. | $73.38 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.43 | 2020-2024 | Jardiance |
| Cardiovascular Systems INC. | $47.90 | 2020-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $45.61 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $24.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $24.49 | 2019 | |
| Shockwave Medical, INC | $23.37 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.94 | 2021 | |
| Alnylam Pharmaceuticals INC. | $15.53 | 2025 | Onpattro |
| Novo Nordisk INC | $13.20 | 2022 | |
| Cmp Pharma, INC. | $12.78 | 2023 | Carospir, Norliqva, Tadliq |
| Cook Medical LLC | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.